Possible role for human leukocyte antigen haplotype in rofecoxib-associated acute pancreatitis and cholestatic hepatitis

Clinical Pharmacology and Therapeutics

Volumn 80, Issue 5, 2006, Pages 554-555

  Sato, Ken ^a   Yamada, Eijirou ^a   Uehara, Yutaka ^a   Takagi, Hitoshi ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; HLA A33 ANTIGEN; HLA ANTIGEN CLASS 1; HLA B44 ANTIGEN; HLA DR6 ANTIGEN; LEUKOCYTE ANTIGEN; ROFECOXIB; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ACUTE PANCREATITIS; CHOLESTATIC HEPATITIS; COMPUTER ASSISTED TOMOGRAPHY; HAPLOTYPE; HEREDITY; HLA SYSTEM; HUMAN; KNEE OSTEOARTHRITIS; LETTER; LIVER BIOPSY; PRIORITY JOURNAL;

AGED; CHOLESTASIS, INTRAHEPATIC; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; HAPLOTYPES; HLA ANTIGENS; HUMANS; LACTONES; OSTEOARTHRITIS; PANCREATITIS, ACUTE NECROTIZING; SULFONES;

EID: 33750956753     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2006.08.007     Document Type: Letter

References (5)

1. Lee Y.S., Kim H., Wu T.X., Wang X.M., and Dionne R.A. Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs. Clin Pharmacol Ther 79 (2006) 407-418
2. Carrillo-Jimenez R., and Nurnberger M. Celecoxib-induced acute pancreatitis and hepatitis: a case report. Arch Intern Med 160 (2000) 553-554
3. Amaravadi R.K., Jacobson B.C., Solomon D.H., and Fischer M.A. Acute pancreatitis associated with rofecoxib. Am J Gastroenterol 97 (2002) 1077-1078
4. Huster D., Schubert C., Berr F., Mossner J., and Caca K. Rofecoxib-induced cholestatic hepatitis: treatment with molecular adsorbent recycling system (MARS). J Hepatol 37 (2002) 413-414
5. Kurosaki M., Takagi H., and Mori M. HLA-A33/B44/DR6 is highly related to intrahepatic cholestasis induced by tiopronin. Dig Dis Sci 45 (2000) 1103-1108